GlassScriptPhysician profile
Chadwick Bryce Royster
NPI 1477995892
$2,946.68
in general payments reported to CMS, 2019-2025
18 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $597 · 2022: $862 · 2023: $874 · 2024: $367 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $948.45 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.95 | 2021-2022 | |
| Boston Scientific Corporation | $228.32 | 2023-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Astrazeneca Pharmaceuticals LP | $191.88 | 2021-2024 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $180.35 | 2021-2024 | Xarelto |
| Amgen INC. | $177.27 | 2021-2025 | Repatha |
| Esperion Therapeutics, INC. | $156.29 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $154.51 | 2021-2023 | |
| Abbott Laboratories | $152.19 | 2023-2025 | Amplatzer Talisman, Mitraclip, Triclip |
| Pfizer INC. | $149.71 | 2022-2024 | |
| Medtronic, INC. | $119.92 | 2021-2022 | |
| Irhythm Technologies, INC. | $117.16 | 2021 | |
| Merck Sharp & Dohme LLC | $46.85 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $22.60 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.66 | 2023 | Inpefa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $17.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.51 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadwick Royster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.